Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2022-04-14 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
2021年度独立董事述职报告（汪思佳）
Board/Management Information Classification · 95% confidence The document is titled as an independent director's annual performance report for the year 2021. It details the attendance of the independent director at board and shareholder meetings, opinions expressed on various company matters, supervision activities, and other work related to governance and investor protection. The content focuses on the director's duties, governance oversight, and compliance with legal and regulatory requirements. It does not contain financial statements or audit results, nor is it a transcript, announcement, or presentation. This type of document fits best under Board/Management Information (MANG) as it relates to the activities and reports of a board member rather than a full annual report or audit report.
2022-04-14 Chinese
2021年度独立董事述职报告（李广超）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2021 Annual Work Report" for Chengdu Berry Genomics Co., Ltd. It details the independent director's attendance at board and shareholder meetings, opinions on various board resolutions, supervision of company governance, and other duties performed during the 2021 fiscal year. The content focuses on the director's role, governance oversight, and compliance with legal and regulatory requirements. It does not contain financial statements or detailed financial performance data. This type of document is a management or board-related report focusing on governance and director duties rather than a full annual report or audit report. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is under 5,000 characters, but it is a substantive report, not merely an announcement or certification, so it is not RPA or RNS. Hence, the classification is MANG with high confidence.
2022-04-14 Chinese
独立董事关于2021年度内部控制自我评价报告的独立意见
Audit Report / Information Classification · 95% confidence The document is an independent opinion from the independent directors regarding the company's 2021 internal control self-evaluation report. It references regulatory frameworks and internal control systems but does not contain the full internal control report itself. The document is relatively short (631 characters) and serves as an opinion or certification on the internal control report rather than the report itself. This fits the category of an Audit Report / Information (AR), which includes audit reports, applied accounting principles, and internal control evaluations separate from full annual reports. FY 2021
2022-04-14 Chinese
内部控制鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as an "内部控制审计报告" (Internal Control Audit Report) for the fiscal year ending December 31, 2021, issued by a certified public accounting firm. It contains detailed evaluation of the company's internal control over financial reporting and non-financial reporting, including the scope, methodology, and conclusions about the effectiveness of internal controls. The document includes audit opinions, internal control evaluation conclusions, and descriptions of internal control systems and risk areas. It is not a full annual report but a standalone audit report focused on internal control effectiveness. Therefore, it fits the category of Audit Report / Information (AR). The document length (over 10,000 characters) and detailed content confirm it is the report itself, not just an announcement or certification. Hence, the classification is AR with high confidence. FY 2021
2022-04-14 Chinese
2021年度监事会工作报告
Management Reports Classification · 95% confidence The document is titled as the "2021年度监事会工作报告" which translates to "2021 Supervisory Board Work Report". It details the supervisory board's activities, oversight of company operations, financial management, internal controls, and compliance with laws and regulations for the year 2021. The content includes summaries of meetings, audit opinions, internal control evaluations, and future plans. It is a formal report from the supervisory board rather than a full annual report or audit report. The document length is about 3010 characters, which is relatively short and focused on supervisory board work rather than comprehensive financial statements or audit details. This fits the category of a Management Report (MDA), which includes management's detailed explanation of financial results, business trends, and outlook, especially from the supervisory board perspective. It is not an announcement or a certification, so it is not RPA or RNS. Therefore, the best classification is Management Reports (MDA).
2022-04-14 Chinese
独立董事关于聘请公司2022年度审计机构的事前认可意见
Audit Report / Information Classification · 90% confidence The document is a formal opinion from independent directors regarding the pre-approval of the appointment of the company's 2022 annual audit firm. It references regulatory rules and governance standards related to audit appointments. The content is focused on the approval process for the audit firm rather than the audit report itself. The document length is short (526 characters), and it does not contain any financial statements or substantive financial data. Therefore, it is not an audit report or annual report but rather an announcement or opinion related to audit firm appointment. This fits best under Audit Report / Information (AR) as it relates to audit matters but is not the full audit report itself. Confidence is high due to clear context and content. FY 2022
2022-04-14 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.